コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 an transmission of the west African clade of monkeypox virus.
2 feared but now eradicated virus, as well as monkeypox virus.
3 d sensitive assays used for the detection of monkeypox virus.
4 375 individuals that tested positive for the monkeypox virus.
5 une regime (69 U/ml) prior to challenge with monkeypox virus.
6 olog was maintained in many OPXVs, including monkeypox virus.
7 an outbreak of the west African clade of the monkeypox virus.
8 ion from a lethal intravenous challenge with monkeypox virus.
9 a, vaccinia, camelpox, mousepox, cowpox, and monkeypox virus.
10 d new and emerging infectious agents such as monkeypox virus.
11 ase after an otherwise lethal challenge with monkeypox virus.
12 d 94.1% sensitivity and 100% specificity for monkeypox virus.
13 mpox, a disease caused by infection with the monkeypox virus.
14 ly conserved in most, including smallpox and monkeypox viruses.
20 lymerase chain reaction on a rectal swab for Monkeypox virus after a recent trip to Brazil, where he
21 oing unprecedented community transmission of monkeypox virus among gay, bisexual, and other men who h
22 onkeypox is a zoonotic illness caused by the monkeypox virus, an Orthopoxvirus in the same genus as t
24 by vaccinia virus vaccines are conserved in monkeypox virus and can elicit memory T cell responses,
25 r.IMPORTANCE Several OPXV species, including monkeypox virus and cowpox virus, cause zoonotic infecti
27 uspected mpox, 31 of which were positive for monkeypox virus and were included in our analysis (four
28 es of three outbreaks as yellow fever virus, monkeypox virus, and a noninfectious cause, the latter u
29 thogenic orthopoxviruses like variola virus, monkeypox virus, and cowpox virus (CPXV), but not vaccin
31 accinia virus, the emerging infectious agent monkeypox virus, and the potential biothreat variola vir
32 r both, and the experiences with SARS-CoV-2, monkeypox virus, and Zika virus highlight the feasibilit
33 reexpansion in association with sterile anti-monkeypox virus (anti-MPV) immunity after MPV challenge.
34 causative agent of smallpox, and the related monkeypox virus are both select agents that, if purposef
36 macaques were challenged intravenously with monkeypox virus at 4, 6, 10, and 30 days after immunizat
37 enetic constrains are sufficient to diminish monkeypox virus' capacity for enhanced specificity as a
38 e macaques were not protected against lethal monkeypox virus challenge if their CD4(+) cell count was
40 us compound ST-246 in prairie dogs against a monkeypox virus challenge of 65 times the 50% lethal dos
45 ception, exhibiting extreme vulnerability to monkeypox virus, cowpox virus, and vaccinia virus and th
51 ection of 100 genome copies per reaction for monkeypox virus, effectively distinguishing it from othe
53 odeoxyglucose ([(18)F]-FDG) in monkeys after monkeypox virus exposure to monitor the immune response
54 ocuments the isolation and identification of monkeypox virus from humans in the Western Hemisphere.
55 nvestigated environmental contamination with monkeypox virus from infected patients admitted to isola
56 museum specimens, as reported previously for monkeypox virus genomes from historical orangutan specim
58 med a retrospective cross-sectional study of monkeypox virus genomic sequences among PCR-confirmed mp
59 ies outside of Africa, despite the fact that monkeypox virus has been causing disease in parts of Afr
60 usly limited to endemic areas with clade 1a, monkeypox virus has recently spread to non-endemic regio
62 022, the world was alerted to circulation of monkeypox virus in many high-income countries outside of
64 ain reaction and culture revealed infectious monkeypox virus in skin lesions of all 3 patients; 2 pat
65 5% CrI: 55.78, 86.85) of infections with the monkeypox virus in the UK were captured over the outbrea
66 ed a valuable nonhuman animal model in which monkeypox virus infection closely resembles human system
67 nd November, 2022, global outbreaks of human monkeypox virus infection have been reported in more tha
68 demiological and clinical characteristics of monkeypox virus infection in cisgender (cis) and transge
72 locations with high numbers of diagnoses of monkeypox virus infection were approached and invited to
73 ted data for a total of 136 individuals with monkeypox virus infection who presented between May 11 a
75 ted with VV, 7 individuals with a history of monkeypox virus infection, and 8 individuals with a hist
82 n facilities and potential for suspension of monkeypox virus into the air during specific activities.
89 uses smallpox) is the most pathogenic, while monkeypox virus is intermediate in pathogenicity between
93 monstrate that the Poxviridae family members monkeypox virus (MPX) and variola virus (VarV) use conse
96 a virus (VACV) antigens B5, A27, and A33 and monkeypox virus (MPXV) antigens E8, B6, B2, M1, A27, A35
97 cted on surface carriers inoculated with the monkeypox virus (MPXV) by applying six disinfectant solu
100 which modified M1, A35 and B6 proteins from monkeypox virus (MPXV) clade Ia are conjugated individua
101 ria in 2019-2020 reveal multiple lineages of monkeypox virus (MPXV) co-circulated in humans for sever
102 Here we determined the apo structure of monkeypox virus (MPXV) Core(Pro) and the structure of Co
108 e prevalence of large deletions in clade IIb monkeypox virus (MPXV) genomes during the global 2022 ou
116 resulted from zoonotic spillover of clade I monkeypox virus (MPXV) in Central Africa and clade II MP
117 RNAscope detected abundant replication of monkeypox virus (MPXV) in epithelial cells and dendritic
118 ivity has been associated with the spread of monkeypox virus (MPXV) in the ongoing, global 2022 epide
120 nd unvaccinated patients, and hypotheses for monkeypox virus (MPXV) infection after vaccination.
131 Infection of nonhuman primates (NHPs) with monkeypox virus (MPXV) is currently being developed as a
137 nd clinical data associated with 18 cases of monkeypox virus (MPXV) isolated from 19 clinical samples
138 was caused by a subclade IIb descendant of a monkeypox virus (MPXV) lineage traced back to Nigeria in
145 mpox driven by unprecedented human-to-human monkeypox virus (MPXV) transmission, we designed BNT166,
146 ntly, a sustained human-to-human outbreak of monkeypox virus (MPXV), a member of the Orthopoxvirus ge
149 facing a second wave of infections from the monkeypox virus (MPXV), characterized by an exponential
150 the evidence for respiratory transmission of monkeypox virus (MPXV), examining key works from animal
152 (Mpox), a zoonotic illness triggered by the monkeypox virus (MPXV), poses a significant threat since
154 sing PD-IRIS, we quantitatively detected the Monkeypox virus (MPXV), the etiological agent for Monkey
156 x outbreak highlighted the serious threat of monkeypox virus (MPXV), yet effective treatments are lac
157 ssay reliably detected antibody responses in monkeypox virus (MPXV)- and vaccinia virus (VACV)-expose
159 e United States following the importation of monkeypox virus (MPXV)-infected animals in a consignment
160 Prior to this outbreak, the durability of monkeypox virus (MPXV)-specific immunity induced by MVA-
165 cted individuals are key factors driving the monkeypox virus (now termed mpox virus or MPXV) outbreak
168 t of testing in the United States during the monkeypox virus outbreak and support restricting the num
171 mergencies, like the SARS-CoV-2 pandemic and monkeypox virus outbreak, continue to have a major effec
172 ata sets of SARS-CoV-2, influenza virus, and monkeypox viruses, outlining the public health utility o
173 ys: RealStar Orthopoxyvirus PCR and FlexStar Monkeypox virus PCR (Altona Diagnostics), Novaplex MPXV
176 oratories successfully implemented the human monkeypox virus primer scheme in various amplicon sequen
177 agnostics), Novaplex MPXV (Seegene), VIASURE Monkeypox virus Real Time PCR Reagents (CerTest Biotec),
179 protein (OMCP) is conserved among cowpox and monkeypox viruses, secreted by infected cells, and bound
180 equences from this study clustering with two monkeypox virus sequences from the current DR Congo outb
182 d from the coronavirus, the emergence of the monkeypox virus signaled a potential new pandemic, highl
184 transmission dynamics and suggests that any monkeypox virus subclade has the potential to cause sust
185 elting temperature [T(m)], 56.40 degrees C), monkeypox virus (T(m), 56.24 degrees C), and vaccinia vi
186 (m)s, 61.7 to 62.7 degrees C), 15 strains of monkeypox virus (T(m)s, 61.9 to 62.2 degrees C), 40 stra
187 lScheme to develop a primer scheme for human monkeypox virus that can be used with many sequencing an
188 nt of smallpox (variola virus), the zoonotic monkeypox virus, the vaccine and zoonotic species vaccin
190 rowth rates of cases by reporting date, when monkeypox virus was confirmed and reported to UKHSA, wer
193 In May 2022, individuals infected with the monkeypox virus were detected in the UK without clear tr
195 s E virus and SARS-CoV-2, and one DNA virus, monkeypox virus, which either primarily or secondarily a
196 uring human infections with the smallpox and monkeypox viruses, which are highly homologous to ectrom
197 % identity in all orthopoxviruses except for monkeypox viruses, whose O3 homologs have 2 to 3 amino a
198 that tested presumptively positive for human monkeypox virus with amplicon-based and metagenomic sequ